<DOC>
	<DOCNO>NCT01091220</DOCNO>
	<brief_summary>The primary objective study evaluate effect certolizumab pegol ( CZP ) quality sperm obtain healthy male volunteer .</brief_summary>
	<brief_title>Evaluation Effects Certolizumab Pegol Semen Quality Healthy Male Volunteers</brief_title>
	<detailed_description>CZP PEGylated humanize Fab ' fragment specificity human tumor necrosis factor alpha ( TNFα ) . Evidence suggest modulation TNFα signaling may affect male spermatogenesis . Therefore , study compare semen quality parameter single 400 mg dose CZP , match placebo .</detailed_description>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>Healthy male volunteer normal baseline semen quality parameter Previous participation study involve TNF inhibitor Prior treatment biologic response modifier within 5 halflives History trauma surgery pelvis/genital area Tests positive tuberculosis , HIV , Hepatitis B C</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>certolizumab pegol</keyword>
	<keyword>Cimzia®</keyword>
	<keyword>healthy male volunteer</keyword>
	<keyword>sperm</keyword>
</DOC>